InTest Corporation

NYSEAM:INTT Stock Report

Market Cap: US$215.9m

InTest Future Growth

Future criteria checks 3/6

InTest is forecast to grow earnings and revenue by 35.9% and 6.8% per annum respectively while EPS is expected to grow by 35.4% per annum.

Key information

35.9%

Earnings growth rate

35.42%

EPS growth rate

Semiconductor earnings growth26.3%
Revenue growth rate6.8%
Future return on equityn/a
Analyst coverage

Low

Last updated06 May 2026

Recent future growth updates

Recent updates

Narrative Update • May 03

INTT: Solid 2026 Outlook And Q4 Execution Will Support Measured Upside Potential

Analysts have raised their price expectations for inTEST to a range of about $14 to $19. They cited better-than-expected Q4 results and "solid" guidance through 2026 as the basis for the higher targets.
Narrative Update • Apr 18

INTT: Multiyear Guidance Will Test Rich Rogoff’s Execution Against High Expectations

Analysts have lifted their price target on inTEST to $14 from $10, citing better-than-expected Q4 results, solid 2026 guidance, and updated assumptions for higher revenue growth and profit margins within a similar forward P/E framework. Analyst Commentary Recent research updates point to a mixed read for inTEST, with higher price targets anchored to Q4 outperformance and 2026 guidance, but also a clear sense that valuation, execution, and growth risk still matter for investors.
Narrative Update • Apr 04

INTT: Q4 Beat And 2026 Outlook Will Support Higher Market Repricing

Analyst price targets on inTEST have shifted from a prior fair value estimate of about $10 to roughly $17.67, with the move supported by recent Q4 outperformance and "solid" 2026 guidance that prompted Street targets in the $14 to $19 range. Analyst Commentary Bullish Takeaways Bullish analysts point to the better than expected Q4 results as support for the higher fair value range, suggesting recent execution is tracking ahead of what was previously baked into targets around $10.
Narrative Update • Mar 20

INTT: Solid 2026 Guidance And Q4 Execution Will Support Higher Earnings Multiple

Analysts have nudged their fair value estimate for inTEST up from $19 to $20, citing recent price target increases to $14 and $19 following better-than-expected Q4 results and solid 2026 guidance. Analyst Commentary Bullish analysts are pointing to inTEST's recent Q4 results and 2026 guidance as key reasons for lifting their fair value views, reflected in updated price targets of $14 and $19.
Narrative Update • Mar 06

INTT: Raised Outlook Into 2026 Will Support Repriced Earnings Multiple

Analysts have lifted their price target on inTEST to $19 from $12, citing recent Q4 outperformance, "solid" guidance into 2026, and updated assumptions for revenue growth, profit margins, discount rate, and future P/E. Analyst Commentary Bullish analysts are pointing to inTEST's recent Q4 performance and the company's guidance into 2026 as key reasons for lifting their valuation ranges.
Narrative Update • Feb 20

INTT: Medical Device Test Order Will Support Balanced Outlook Through 2026

Analysts have slightly adjusted their price targets on inTEST, reflecting small refinements to discount rate, revenue growth, profit margin and future P/E assumptions within their updated models. Taken together, these changes point to a modestly revised view of the stock's potential value in dollar terms.
Narrative Update • Feb 06

INTT: Medical Device Testing Expansion Will Support Measured Outlook For 2026 Recovery

Analysts have trimmed their fair value estimate for inTEST to $10.00. This reflects slightly lower discount rate and future P/E assumptions alongside modestly adjusted revenue growth and profit margin expectations.
Narrative Update • Jan 21

INTT: Transition-Year Execution Will Set Up 2026 Recovery And Undervalued Upside

Analysts have raised their price target on inTEST to US$10 from US$8, indicating increased confidence in the company's longer term growth outlook as it moves past a transition year. Analyst Commentary Recent research highlights a more optimistic stance on inTEST, with the latest work describing 2025 as a transition year and pointing to the potential for growth in 2026.
Narrative Update • Jan 07

INTT: Transition-Year Execution And 2026 Recovery Outlook Will Support Bullish Thesis

Narrative Update: Analyst Price Target Shift for inTEST The consensus analyst price target for inTEST has moved up by US$2 to US$10 per share. This reflects analysts' higher confidence in the company's outlook as it progresses through a transition year and they look ahead to 2026.
Narrative Update • Dec 15

INTT 2026 Recovery Outlook Will Drive Confidence In Transition-Year Progress

Analysts have raised their price target on inTEST to $10 from $8 per share, reflecting increased confidence in the company’s positioning for a return to growth after its current transition period. Analyst Commentary Recent research commentary reflects a cautiously optimistic stance, with the latest price target increase framed against a backdrop of execution and macro risks that could weigh on the pace of inTEST's recovery.
User avatar
New Narrative • Feb 09

Alfamation Integration And Malaysian Expansion Will Strengthen Future Prospects

Integration with Alfamation and innovative product lines are enhancing revenue and margins, leveraging synergies, and expanding the customer base.

Earnings and Revenue Growth Forecasts

NYSEAM:INTT - Analysts future estimates and past financials data (USD Millions)
DateRevenueEarningsFree Cash FlowCash from OpAvg. No. Analysts
12/31/20281498N/A131
12/31/202714378103
12/31/202613439113
3/31/20261211-4-2N/A
12/31/2025114-367N/A
9/30/2025118-21011N/A
6/30/2025122-11012N/A
3/31/2025128067N/A
12/31/2024131324N/A
9/30/2024122346N/A
6/30/2024123578N/A
3/31/202412171416N/A
12/31/202312391516N/A
9/30/2023128111214N/A
6/30/20231281189N/A
3/31/20231251134N/A
12/31/20221178-3-1N/A
9/30/20221076-2-1N/A
6/30/202297512N/A
3/31/202289678N/A
12/31/20218571011N/A
9/30/202177789N/A
6/30/202171567N/A
3/31/202162223N/A
12/31/202054-133N/A
9/30/202053023N/A
6/30/202053012N/A
3/31/202054001N/A
12/31/2019612N/A-8N/A
9/30/2019651N/A-5N/A
6/30/2019710N/A-2N/A
3/31/2019784N/A-1N/A
12/31/2018793N/A11N/A
9/30/201880-1N/A9N/A
6/30/2018772N/A10N/A
3/31/201871-1N/A11N/A
12/31/2017671N/A7N/A
9/30/2017587N/A8N/A
6/30/2017516N/A5N/A
3/31/2017465N/A4N/A
12/31/2016403N/A4N/A
9/30/2016382N/A2N/A
6/30/2016361N/A3N/A
3/31/2016372N/A3N/A
12/31/2015392N/A3N/A
9/30/2015413N/A6N/A
6/30/2015423N/A5N/A

Analyst Future Growth Forecasts

Earnings vs Savings Rate: INTT's forecast earnings growth (35.9% per year) is above the savings rate (3.5%).

Earnings vs Market: INTT's earnings (35.9% per year) are forecast to grow faster than the US market (16.4% per year).

High Growth Earnings: INTT's earnings are expected to grow significantly over the next 3 years.

Revenue vs Market: INTT's revenue (6.8% per year) is forecast to grow slower than the US market (11.4% per year).

High Growth Revenue: INTT's revenue (6.8% per year) is forecast to grow slower than 20% per year.

Earnings per Share Growth Forecasts

Future Return on Equity

Future ROE: Insufficient data to determine if INTT's Return on Equity is forecast to be high in 3 years time

Discover growth companies

7D

1Y

7D

1Y

7D

1Y

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2026/05/07 06:07
End of Day Share Price 2026/05/07 00:00
Earnings2026/03/31
Annual Earnings2025/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

InTest Corporation is covered by 4 analysts. 3 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Maxwell MichaelisLake Street Capital Markets, LLC
Edward JacksonNorthland Capital Markets
Richard RyanOak Ridge Financial Services Group Inc.